The most effective modern medical practices in the world heal through access rather than by dazzle with their intricacy. By 2026, the length of the bridge to reach the underprivileged will be the true measure of innovation, not the height of a lab’s ivory tower. Being a leader in this day and age means having two souls: a social architect who dismantles the financial barriers that prevent many people from accessing life-saving assistance, and a rigorous scientist who deciphers the silent language of pain medicine.
In pain management, innovation is no longer defined by complexity but by two core priorities: accessibility and affordability. Dr. Krishnan Chakravarthy has chosen to tackle these challenges directly, working to make advanced pain treatments accessible at scale while lowering the cost of care. For him, the measure of progress is simple: if effective pain treatment does not reach the patients who need it most, it fails its purpose.
For decades, limited access to scalable, affordable alternatives has quietly shaped the trajectory of pain care, leaving many patients caught between inadequate relief and unsustainable treatment pathways. In this landscape, opioids emerged not as a simple choice but as a consequence of limited options. Dr. Chakravarthy’s goal is not incremental adjustment but a deeper transformation of the pain space, building front-end therapies that intervene earlier and open new possibilities for how pain can be understood and treated.
This is the narrative of a pioneer who views the pulse of progress through the lens of human equity- a leader who understands that a miracle is only truly miraculous when it is available to everyone.
The Genesis of a Global Perspective
Born in Chennai, India, and raised in the United States, his early life unfolded across two cultures and systems of opportunity. When his father left a stable engineering role to pursue advanced education in America, the move reflected a belief in education as a pathway to transformation and access.
Arriving in Columbus, Ohio at a young age, he experienced firsthand the uncertainty that comes with starting over in a new country. Navigating unfamiliar systems shaped an early awareness of how access and opportunity are influenced by circumstance, a perspective that would later inform his approach to healthcare and the barriers patients face.
His formative years in Buffalo, New York further shaped his outlook. Surrounded by ambitious peers at Williamsville East High School, he developed a mindset grounded in discipline, adaptability, and sustained effort. The experience reinforced a belief that lasting impact is built through persistence and a willingness to redefine one’s path.
Academic Excellence and the Scientific Foundation
Krishnan’s academic trajectory led him to the University of Chicago, an institution where his intellectual curiosity truly blossomed. Initially a math major, he soon pivoted toward a pre-medical path within a liberal arts framework. This diverse education allowed him to expand his scope beyond the hard sciences, incorporating finance and biological sciences into a foundation that defines him to this day.
Krishnan then pursued the elite Medical Scientist Training Program (MSTP), a combined MD/PhD track funded by the National Institutes of Health (NIH). This rigorous eight-year journey provided him with a dual lens: the clinical skills of a physician and the investigative depth of a doctoral researcher. His PhD work in viral immunology focused on host immunity to influenza, where he explored the cutting-edge use of nanomaterial technology for vaccine development.
His training continued at the world’s most prestigious medical centers. Krishnan completed his residency at Johns Hopkins Hospital and his fellowship at Harvard. While he was initially set on a traditional academic career, rising to the rank of Associate Professor at UCSD Health, his entrepreneurial spirit began to fire. By 2022, he made the bold move to the private sector, launching a clinical practice, a surgery center, and several biotechnology enterprises.
The Entrepreneurial Spark: From Lab to Market
The transition from scientist to founder was not a sudden shift but a gradual awakening that began in his mid-20s. While conducting post-graduate work at the Center for Disease Control (CDC) as a doctoral fellow, Krishnan was tasked with developing alternative vaccines for seasonal and pandemic influenza using gene therapy. He leveraged his engineering background to manipulate nanomaterials as delivery mechanisms for signal interference RNA that combat viral replication.
In 2008, Krishnan entered a business plan competition at SUNY Buffalo that seeked to pair medical innovation with business school strategy. He pitched a concept for using nanomaterials as scalable diagnostic and therapeutic delivery devices, specifically utilizing quantum dot technology. He won first place, and his company, NanoAxis, was born. This experience was his “pivotal” moment, teaching him the essential mechanics of building a team and moving core technology from the university lab to the commercial market.
Since that first victory, he has been a relentless force in the biotechnology sector. He has launched and advised numerous organizations including many fortune 500 companies. His companies that he has founded include:
- Innovative Pain Treatment Solutions and Surgery Centers: A muti-disciplinary physician led medical practice and surgery centers spanning various locations in Southern California.
- Solaris Research Institute (SRI): A premiere global neuroscience and pain institute conducting contracted and foundational clinical and translational research.
- Accufix Medical and Douleur Therapeutics: Ventures that prove the “bench-to-bedside” model of innovation focused on novel neurostimulation lead and catheter anchoring technology and novel non-opiate small molecule drug development.
NXTSTIM: A Paradigm Shift in Pain Management
Of all his ventures, NXTSTIM is the one currently radically changing the healthcare landscape at a rapid pace. Founded five years ago, the company operates at a critical intersection of cost, access, and community in the neurostimulation space, reflecting Dr. Chakravarthy’s broader mission to transform pain care through accessibility and affordability.
Dr. Chakravarthy identifies a significant disparity in the pain management industry: traditional implantable neurostimulation treatments can cost nearly $150,000 to the health system. While insurance may cover these procedures for some patients, many remain without access to relief, highlighting a persistent gap between innovation and accessibility.
NXTSTIM has introduced a revolutionary low-cost wearable solution, priced at approximately $150, to bring the best therapy to the masses. The centerpiece of this platform is EcoAI™, a novel wearable non-invasive neurostimulation device. This device is not a static tool; it is an AI-driven platform that utilizes big data and crowdsourced information to tailor therapy to each individual patient. By combining remote therapeutic monitoring with digital health software, NXTSTIM addresses the needs of the one-sixth of the human population affected by chronic pain with a radical approach. EcoAITM is the first theranostic electroceutical using an AI platform for therapy optimization with broad US based insurance coverage, but also low cost allowing for outside US direct to consumer model.
In only eighteen months since its commercial launch, the platform has successfully treated 4,000 patients nationally. The data from real-world clinical trials is staggering, showing significant improvements in pain, sleep, and stress levels over a 24-month period.
At its core, this represents the heart of the NXTSTIM ecosystem, a first-of-its-kind model for personalized pain care.
For Krishnan, this is just the beginning of a journey to reshape the pain management landscape plagued by high cost and low access solutions.
Leadership, Grit, and the Myth of Balance
Dr. Chakravarthy is refreshingly honest about the realities of being a leader at the forefront of innovation. He does not believe in a traditional “work-life balance” for those striving to achieve the extraordinary. To him, work and life are a single, blended passion. He acknowledges the late nights and the sacrifices of personal time that are required to move a concept from a dream to a survival-ready business.
He likes to describe the startup environment with a visceral metaphor: “like chewing broken glass”. It is a world without a roadmap or solid footing, where ingenuity is found in the constant troubleshooting of various circumstances leaders can’t prepare for. In this environment, his leadership philosophy is built on several key pillars:
- Transparency: Being honest with loved ones and staff about the primary focus of the mission.
- Emotional Intelligence: Recognizing that mental intelligence alone is insufficient for building a successful team.
- Grit over Ideas: Understanding that while many have ideas, few have the determination to execute them regardless of the challenges.
- Selfless Leadership: Operating under the mantra, “Don’t ask someone to do something that you won’t do”.
He believes that a leader’s most important function is to ensure every individual understands the collective goal and to provide a mixture of emotional support and data-driven feedback in addition to driving innovation.
Turning Crisis into Resilience
The COVID-19 pandemic was a defining moment for many businesses, but for Dr. Chakravarthy, it was a catalyst for acceleration. While many traditional, labor-intensive businesses struggled, the pandemic forced NXTSTIM to master the art of virtual scaling. He used this period to refine remote communication, virtual sales strategies, and manufacturing protocols during a time of extreme limitation.
Instead of merely surviving, his organization became more resilient. The virtual-based operations and low-cost effective manners adopted during the pandemic became a permanent framework for success. He views this adaptability as one of the strongest indicators of long-term success for any entrepreneur, the ability to pivot rapidly under difficult circumstances.
A Record of Unparalleled Achievement
Dr. Chakravarthy’s work spans a wide range of accomplishments in the field of research, clinical care and leadership:
- Scholarship: He is the author of over 100 papers and has delivered more than 500 talks globally.
- World Expert Status: Expertscape’s algorithms place him in the top 0.1% of scholars writing about Pain Management over the last decade.
- Clinical Pioneer: He is the first physician in the United States to implant the Reactiv-8 restorative neurostimulation device and the first in the US to also implant the first Medtronic closed-loop neurostimulation device, among other landmark clinical achievements. He is a founding faculty member of restorative neurostimulation credited with training countless physicians nationally.
- Award Winner: A three-time recipient of the “BEST in California Magazine” Doctors Excellence in Medicine award (2022, 2023, 2024).
- Academic Influence: He is the current President of the American Society of Pain and Neuroscience (ASPN). He serves on the editorial boards of several national and international peer-reviewed journals and holds many affiliate faculty positions.
His research has been featured in top-tier publications such as Anesthesiology and the Proceedings of the National Academy of Sciences. His work has caught the attention of mainstream media outlets including the Times of India, International Business Times, and NewsMedical.
Advice for the Next Generation of Leaders
To those aspiring to lead, Krishnan offers an inspiring message: leadership requires the courage to stand by decisions that may not align with the interests of influential “power brokers”. He advises leaders to find a consistent message and stick to it, as this consistency is what maintains the team’s conviction in the mission during the constant highs and lows.
He believes that while there is an element of luck in creating a “unicorn” company, he agrees with Louis Pasteur that “chance favors the prepared mind”. Success follows those who put themselves in a position to succeed through hard work, grit, and ingenuity.
A Mantra for Growth and Legacy
Dr. Chakravarthy’s life is driven by a singular idea: if you are truly passionate and give 110%, you will find success, regardless of the specific outcome. He encourages everyone to be a lifelong learner and to embrace being “uncomfortable”. Whether it is learning a new science, dealing with difficult people, or pursuing an idea outside of one’s skill set, these are the ingredients for growth.
Ultimately, his final piece of advice is deeply human: “Trust yourself”. He also reminds fellow entrepreneurs that family and close friends are the only people who will truly remember you in the end. By bringing them along on the journey and sharing the passion, the sacrifice of the entrepreneurial life becomes a shared legacy of meaningful change. Krishnan is not just building businesses; he is building a future where relief is a right, not a privilege.
